On June 3, IBM rose 3.13% in regular trading, trading at approximately $330.63/share, with trading volume of $4.221 billion, extending its recent strong momentum.
On the news front, IBM previously announced a plan to invest over $10 billion over five years in quantum computing R&D, manufacturing scaling, and acquisitions, targeting the delivery of the first large-scale fault-tolerant quantum computer by 2029. The U.S. Department of Commerce is also providing approximately $1 billion under the CHIPS and Science Act to support IBM subsidiary Anderon in becoming the first dedicated quantum chip foundry in the United States. Multiple investment banks have recently raised their target prices: Wedbush lifted its target from $320 to $350, Barclays initiated coverage with an Overweight rating and a $350 target, and Melius Research raised its target to $390, citing long-term value from AI and quantum technology synergies. Since May, IBM shares have surged over 40%, with market capitalization surpassing $300 billion for the first time.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments